The impact of a conjugate pneumcoccal vaccine (Prevenar) on the aetiology of childhood pneumonia in the North East
Phase of Trial: Phase III
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections; Pneumonia
- Focus Therapeutic Use
- 10 Aug 2011 Status changed from recruiting to completed as reported by United Kingdom Clinical Research Network.
- 10 Aug 2011 United Kingdom Clinical Research Network reports accrual to date changed from 71% to 76%.
- 11 Sep 2009 New trial record